X-twitter Linkedin Facebook-f Vimeo

Health

Companies engaged in biotechnology, pharmaceuticals, research services, home healthcare, hospital operations, long‑term care, and the manufacture and supply of medical equipment and supplies. The sector also includes pharmaceutical retailers and providers of health‑information services. UK‑listed companies in this sector include AstraZeneca plc, GlaxoSmithKline plc, Smith & Nephew plc, Hikma Pharmaceuticals plc, ConvaTec Group plc, Spire Healthcare plc and EMIS Group plc.

EDX Medical Group plc

EDX Medical targets corporate health market with new screening service

EDX Medical is preparing to launch a corporate health screening service covering 14,000 employees, with testing expected to begin in Q4 2026...
BIOG

BIOG keeps its focus on small-cap biotech and M&A potential

BIOG remains focused on small-cap biotech and potential takeover targets, with its managers still seeing value across the portfolio...
SN

Smith & Nephew CFO John Rogers to step down in September

Smith & Nephew has announced John Rogers will leave as chief financial officer, with Pierre Palassian appointed interim CFO until a successor is named...
ONT

Oxford Nanopore lifts gross margin and improves EBITDA in H1 2026

Oxford Nanopore reported higher first-half revenue, improved gross margin and updated its 2030 revenue and EBITDA margin targets...
NFX

Nuformix reports positive NXP002 inhalation study results

Nuformix has reported positive inhaled NXP002 preclinical data, supporting pulmonary exposure, target engagement and further development planning...
Genflow Biosciences Plc

Genflow Biosciences moves canine longevity study towards six-month data

Genflow Biosciences is progressing its canine longevity study towards six-month data after reporting encouraging early survival and safety observations...
SN

Smith & Nephew and Imperial College London open surgical robotics innovation centre

Smith & Nephew and Imperial College London have launched a five-year partnership to accelerate research and innovation in robotic surgery...
Verici Dx Plc

Verici Dx targets growing demand for kidney transplant diagnostics

Verici Dx is targeting the expanding kidney transplant diagnostics market as molecular surveillance becomes a larger part of post-transplant care...
AstraZeneca

AstraZeneca reports positive Phase III results for Tagrisso-Orpathys lung cancer combination

Astrazeneca Plc has reported positive SAFFRON Phase III results for Tagrisso and Orpathys, showing improved progression-free and overall survival...
Verici Dx Plc

Verici Dx strengthens commercial case for kidney transplant risk test

Verici Dx has published analysis showing its PTRA kidney transplant risk test could generate more than $191 million in US healthcare savings over two years...
Genflow Biosciences Plc

Healthspan becomes a bigger part of the healthy ageing debate

Healthspan is becoming a key part of the longevity discussion as attention shifts from simply living longer to staying healthier for more of those years...
EDX Medical Group plc

EDX Medical positioned in growing prostate screening push

EDX Medical is positioned in the growing prostate screening debate as demand builds for more accurate, less invasive diagnostic testing...
VRCI

Verici Dx secures Olink Certified Service Provider status

Verici Dx has achieved Olink Certified Service Provider status, expanding its proteomics assay capabilities at its CAP-certified and CLIA-accredited laboratory...
Nuformix plc

Pulmonary fibrosis care needs support a long-term treatment market

Pulmonary fibrosis creates long-term demand for treatments, respiratory equipment and patient-support services as care needs increase over time...
BIOG

Precision medicine and rare disease development expand the targeted biotech opportunity

Precision medicine and rare disease development are creating more focused biotech opportunities built around biomarkers, targeted trials and clearly defined patient groups...
BIOG

Biotech Growth secures major value from Forte Biosciences takeover

Biotech Growth is set to benefit from Argenx’s $2.2 billion acquisition of Forte Biosciences after entering the company at a much lower valuation...
Cizzle Biotechnology Holdings plc

Cizzle Biotechnology begins US commercial launch of lung cancer blood test

Cizzle Biotechnology has started the US commercial rollout of its CIZ1B lung cancer blood test through an initial launch in Texas...
Genflow Biosciences Plc

Genflow nears key data readout for SIRT6 gene therapy platform

Genflow is nearing a key data point as it combines animal study results, specialist RNA delivery support and broader patent protection...
Verici Dx Plc

Verici Dx adds senior transplant experts to support clinical development

Verici Dx has expanded its Scientific Advisory Board with 14 senior transplant and clinical research specialists to support product development and adoption...
SN

Smith & Nephew maintains profit guidance as H1 trading margin improves

Smith & Nephew reported higher half-year revenue, operating profit and cash generation, while reducing full-year revenue guidance...

News and Interview Alerts

Subscribe Free

Company Presentations

Q&As

Hardman & Co

Green News

View all Sustainable sectors, Plcs and news >>  

Search

Search

Latest Interviews

BrokerTalk

Funds

View all Funds, Market Insights and news >> 

FTSE 100 News

UK Broker Ratings

Health

EDX Medical Group plc

EDX Medical targets corporate health market with new screening service

EDX Medical is preparing to launch a corporate health screening service covering 14,000 employees, with testing expected to begin in Q4 2026...
BIOG

BIOG keeps its focus on small-cap biotech and M&A potential

BIOG remains focused on small-cap biotech and potential takeover targets, with its managers still seeing value across the portfolio...
SN

Smith & Nephew CFO John Rogers to step down in September

Smith & Nephew has announced John Rogers will leave as chief financial officer, with Pierre Palassian appointed interim CFO until a successor is named...
ONT

Oxford Nanopore lifts gross margin and improves EBITDA in H1 2026

Oxford Nanopore reported higher first-half revenue, improved gross margin and updated its 2030 revenue and EBITDA margin targets...
NFX

Nuformix reports positive NXP002 inhalation study results

Nuformix has reported positive inhaled NXP002 preclinical data, supporting pulmonary exposure, target engagement and further development planning...
Genflow Biosciences Plc

Genflow Biosciences moves canine longevity study towards six-month data

Genflow Biosciences is progressing its canine longevity study towards six-month data after reporting encouraging early survival and safety observations...
SN

Smith & Nephew and Imperial College London open surgical robotics innovation centre

Smith & Nephew and Imperial College London have launched a five-year partnership to accelerate research and innovation in robotic surgery...
Verici Dx Plc

Verici Dx targets growing demand for kidney transplant diagnostics

Verici Dx is targeting the expanding kidney transplant diagnostics market as molecular surveillance becomes a larger part of post-transplant care...
AstraZeneca

AstraZeneca reports positive Phase III results for Tagrisso-Orpathys lung cancer combination

Astrazeneca Plc has reported positive SAFFRON Phase III results for Tagrisso and Orpathys, showing improved progression-free and overall survival...
Verici Dx Plc

Verici Dx strengthens commercial case for kidney transplant risk test

Verici Dx has published analysis showing its PTRA kidney transplant risk test could generate more than $191 million in US healthcare savings over two years...
Genflow Biosciences Plc

Healthspan becomes a bigger part of the healthy ageing debate

Healthspan is becoming a key part of the longevity discussion as attention shifts from simply living longer to staying healthier for more of those years...
EDX Medical Group plc

EDX Medical positioned in growing prostate screening push

EDX Medical is positioned in the growing prostate screening debate as demand builds for more accurate, less invasive diagnostic testing...
VRCI

Verici Dx secures Olink Certified Service Provider status

Verici Dx has achieved Olink Certified Service Provider status, expanding its proteomics assay capabilities at its CAP-certified and CLIA-accredited laboratory...
Nuformix plc

Pulmonary fibrosis care needs support a long-term treatment market

Pulmonary fibrosis creates long-term demand for treatments, respiratory equipment and patient-support services as care needs increase over time...
BIOG

Precision medicine and rare disease development expand the targeted biotech opportunity

Precision medicine and rare disease development are creating more focused biotech opportunities built around biomarkers, targeted trials and clearly defined patient groups...
BIOG

Biotech Growth secures major value from Forte Biosciences takeover

Biotech Growth is set to benefit from Argenx’s $2.2 billion acquisition of Forte Biosciences after entering the company at a much lower valuation...
Cizzle Biotechnology Holdings plc

Cizzle Biotechnology begins US commercial launch of lung cancer blood test

Cizzle Biotechnology has started the US commercial rollout of its CIZ1B lung cancer blood test through an initial launch in Texas...
Genflow Biosciences Plc

Genflow nears key data readout for SIRT6 gene therapy platform

Genflow is nearing a key data point as it combines animal study results, specialist RNA delivery support and broader patent protection...
Verici Dx Plc

Verici Dx adds senior transplant experts to support clinical development

Verici Dx has expanded its Scientific Advisory Board with 14 senior transplant and clinical research specialists to support product development and adoption...
SN

Smith & Nephew maintains profit guidance as H1 trading margin improves

Smith & Nephew reported higher half-year revenue, operating profit and cash generation, while reducing full-year revenue guidance...
Load More

News and Interview Alerts

Subscribe Free

Company Presentations

Q&As

Hardman & Co

Green News

View all Sustainable sectors, Plcs and news >>  

Search

Search

Latest interviews

Broker Talk

Funds

View all Funds, Market Insights and news >> 

FTSE 100 News

UK Broker Ratings

Health

Latest Interviews

FTSE 100 News

FTSE 250 News

News and Interview Alerts

Subscribe Free

Company Presentations

Q&As

Hardman & Co

BrokerTalk

FTSE 100

Funds

View all Funds, Market Insights and news >> 

Green News

View all Sustainable sectors, Plcs and news >>  

UK Broker Ratings

Follow us on Social Media:

Home X-twitter Linkedin Facebook Spotify Apple